What is the share price of Chandan Healthcare Ltd (CHANDAN) today?
The share price of CHANDAN as on 2nd March 2026 is ₹257. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Chandan Healthcare Ltd (CHANDAN) share?
The past returns of Chandan Healthcare Ltd (CHANDAN) share are- Past 1 week: -3.49%
- Past 1 month: -2.28%
- Past 3 months: -19.57%
- Past 6 months: 13.72%
- Past 1 year: 71.68%
- Past 3 years: N/A%
- Past 5 years: 48.25%
What are the peers or stocks similar to Chandan Healthcare Ltd (CHANDAN)?
The peers or stocks similar to Chandan Healthcare Ltd (CHANDAN) include:What is the market cap of Chandan Healthcare Ltd (CHANDAN) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Chandan Healthcare Ltd (CHANDAN) is ₹628.42 Cr as of 2nd March 2026.What is the 52 week high and low of Chandan Healthcare Ltd (CHANDAN) share?
The 52-week high of Chandan Healthcare Ltd (CHANDAN) is ₹358 and the 52-week low is ₹140.What is the PE and PB ratio of Chandan Healthcare Ltd (CHANDAN) stock?
The P/E (price-to-earnings) ratio of Chandan Healthcare Ltd (CHANDAN) is 28.35. The P/B (price-to-book) ratio is 4.97.Which sector does Chandan Healthcare Ltd (CHANDAN) belong to?
Chandan Healthcare Ltd (CHANDAN) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Chandan Healthcare Ltd (CHANDAN) shares?
You can directly buy Chandan Healthcare Ltd (CHANDAN) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Chandan Healthcare Ltd
CHANDAN Share Price
NSE₹257.001.19% (-3.10)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
CHANDAN Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CHANDAN Performance & Key Metrics
CHANDAN Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 23.99 | 4.97 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 36.71 | 5.79 | 0.58% |
CHANDAN Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CHANDAN Company Profile
Chandan Healthcare Ltd operates medical stores offering a variety of pharmaceutical products, including consumables, injectables, and health monitoring services, with a focus on disease prevention and laboratory testing.
SUNPHARMA
PE Ratio
38.47
38.47
1Y Return
10.56%
10.56%
Buy Reco %
94.29
94.29
TORNTPHARM
PE Ratio
77.37
77.37
1Y Return
47.65%
47.65%
Buy Reco %
81.48
81.48
CIPLA
PE Ratio
20.71
20.71
1Y Return
3.97%
3.97%
Buy Reco %
54.84
54.84
DRREDDY
PE Ratio
19.06
19.06
1Y Return
15.61%
15.61%
Buy Reco %
48.39
48.39
LUPIN
PE Ratio
32.19
32.19
1Y Return
18.34%
18.34%
Buy Reco %
72.22
72.22
CHANDAN Forecast
CHANDAN Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
CHANDAN
CHANDAN
Income
Balance Sheet
Cash Flow
Quarterly Normal View
CHANDAN Income Statement
CHANDAN Income Statement
Quarterly Normal View
| Quarter | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 54.82 | 64.18 | 68.75 | 68.75 | 65.77 | |||||
Operating & Other expenses | 45.75 | 51.53 | 53.75 | 53.75 | 55.39 | |||||
EBITDA | 9.07 | 12.65 | 15.00 | 15.00 | 10.38 | |||||
| Depreciation/Amortization | 1.35 | 2.70 | 2.46 | 2.46 | 2.40 | |||||
| PBIT | 7.72 | 9.95 | 12.54 | 12.54 | 7.98 | |||||
| Interest & Other Items | 1.09 | 1.30 | 1.40 | 1.40 | 1.28 | |||||
| PBT | 6.63 | 8.65 | 11.14 | 11.14 | 6.70 | |||||
| Taxes & Other Items | 2.42 | 2.63 | 3.33 | 3.32 | 2.16 | |||||
| Net Income | 4.21 | 6.02 | 7.81 | 7.82 | 4.54 | |||||
| EPS | 2.10 | 2.46 | 3.19 | 3.19 | 1.86 |
CHANDAN Company Updates
CHANDAN Stock Peers
CHANDAN Past Performance & Peer Comparison
CHANDAN Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Chandan Healthcare Ltd | 28.35 | 4.97 | — |
| Sun Pharmaceutical Industries Ltd | 38.47 | 5.80 | 0.91% |
| Torrent Pharmaceuticals Ltd | 77.37 | 19.48 | 0.73% |
| Cipla Ltd | 20.71 | 3.49 | 1.18% |
CHANDAN Stock Price Comparison
Compare CHANDAN with any stock or ETFCompare CHANDAN with any stock or ETF
CHANDAN
CHANDAN Holdings
CHANDAN Shareholdings
CHANDAN Promoter Holdings Trend
CHANDAN Promoter Holdings Trend
CHANDAN Institutional Holdings Trend
CHANDAN Institutional Holdings Trend
Increased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has increased by 1.62%
Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has decreased by 1.11%
CHANDAN Shareholding Pattern
CHANDAN Shareholding Pattern
CHANDAN Shareholding History
CHANDAN Shareholding History
Foreign Institutions
smallcases containing CHANDAN stock
smallcases containing CHANDAN stock
Looks like this stock is not in any smallcase yet.
CHANDAN Events
CHANDAN Events
CHANDAN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHANDAN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CHANDAN Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CHANDAN has not given any dividends in last 5 years
CHANDAN Dividends
CHANDAN Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCHANDAN Stock News & Opinions
CHANDAN Stock News & Opinions
Articles & Videos
Earnings
Chandan Healthcare consolidated net profit rises 8.10% in the December 2025 quarter
Net profit of Chandan Healthcare rose 8.10% to Rs 4.54 crore in the quarter ended December 2025 as against Rs 4.20 crore during the previous quarter ended December 2024. Sales rose 18.98% to Rs 65.01 crore in the quarter ended December 2025 as against Rs 54.64 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales65.0154.64 19 OPM %18.2116.27 - PBDT11.337.97 42 PBT8.926.62 35 NP4.544.20 8 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Chandan Healthcare announces board meeting date
Chandan Healthcare will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Chandan Healthcare to discuss results
Chandan Healthcare will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Chandan Healthcare to convene EGM
Chandan Healthcare announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 6 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Chandan Healthcare to hold board meeting
Chandan Healthcare will hold a meeting of the Board of Directors of the Company on 10 October 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Chandan Healthcare schedules AGM
Chandan Healthcare announced that the 22th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Chandan Healthcare to discuss results
Chandan Healthcare will hold a meeting of the Board of Directors of the Company on 27 May 2025.Powered by Capital Market - Live
9 months agoCapital Market - Live
Spotlight
NSE SME Chandan Healthcare gains on debut
The scrip was listed at 165.10, a premium of 3.84% over the initial public offer (IPO) price. The stock was currently up 1.48% over its listing price. The counter hit a high of Rs 173.35 and a low of Rs 165.10. About 27.20 lakh shares of the company changed hands at the counter. Chandan Healthcare's IPO was subscribed 6.62 times. The issue opened for bidding on 10 February 2025 and it closed on 12 February 2025. The price band of the IPO was set at Rs 151 to Rs 159 per share. The issue size comprised fresh issue of 26,03,264 and offer for sale (OFS) of 22,99,936 shares by existing promoters. The company intends to utilize the net proceeds for setting up a new flagship diagnostic center in Jankipuram, Lucknow, Uttar Pradesh, setting up a new central reference laboratory in Ayodhya, Uttar Pradesh, setting up a new central reference laboratory in Ashiyana, Lucknow, Uttar Pradesh and for general corporate purposes. Ahead of Chandan Healthcare on 7 February 2025, raised Rs 29.39 crore from anchor investors. The board has allotted 18.48 lakh shares at Rs 159 per share to 14 anchor investors. Chandan Healthcare operates a diagnostic network across North India, providing pathology and radiology services. Their network includes a flagship lab, nine central labs, 27 satellite centers, and over 300 collection centers, spanning more than 23 cities and towns in Uttar Pradesh and over 19 in Uttarakhand. Notably, eight of their labs hold NABL accreditation, and three diagnostic centers are NABH accredited. As of 31 December 2024, the company had 1,142 employees. The company recorded revenue from operations of Rs 167.47 crore and net profit of Rs 17.41 crore for the period ended 31 March 2024. Powered by Capital Market - Live
1 year agoCapital Market - Live
Pledged promoter holdings is insignificant